Ampio Pharmaceuticals Inc (AMPE) Sees Unusually-High Trading Volume
Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) shares saw unusually-strong trading volume on Thursday . Approximately 6,826,500 shares changed hands during mid-day trading, an increase of 1,274% from the previous session’s volume of 496,659 shares.The stock last traded at $1.75 and had previously closed at $1.37.
Separately, ValuEngine upgraded shares of Ampio Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research report on Wednesday, October 11th.
Ampio Pharmaceuticals Company Profile
Ampio Pharmaceuticals, Inc is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company’s two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema.
Receive News & Stock Ratings for Ampio Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals Inc and related stocks with our FREE daily email newsletter.